Cargando…
Retinitis Pigmentosa: Current Clinical Management and Emerging Therapies
Retinitis pigmentosa (RP) comprises a group of inherited retinal dystrophies characterized by the degeneration of rod photoreceptors, followed by the degeneration of cone photoreceptors. As a result of photoreceptor degeneration, affected individuals experience gradual loss of visual function, with...
Autores principales: | Nguyen, Xuan-Thanh-An, Moekotte, Lude, Plomp, Astrid S., Bergen, Arthur A., van Genderen, Maria M., Boon, Camiel J. F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10139437/ https://www.ncbi.nlm.nih.gov/pubmed/37108642 http://dx.doi.org/10.3390/ijms24087481 |
Ejemplares similares
-
CRB1-Associated Retinal Dystrophy Patients Have Expanded Lewis Glycoantigen-Positive T Cells
por: Moekotte, Lude, et al.
Publicado: (2023) -
The Lrat(−/−) Rat: CRISPR/Cas9 Construction and Phenotyping of a New Animal Model for Retinitis Pigmentosa
por: Koster, Céline, et al.
Publicado: (2021) -
Artificial vision: the effectiveness of the OrCam in patients with advanced inherited retinal dystrophies
por: Nguyen, Xuan‐Thanh‐An, et al.
Publicado: (2021) -
Current and Future Treatment of Retinitis Pigmentosa
por: Cross, Nancy, et al.
Publicado: (2022) -
Prediction of visual impairment in retinitis pigmentosa using deep learning and multimodal fundus images
por: Liu, Tin Yan Alvin, et al.
Publicado: (2023)